Publication | Open Access

Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase

Alzheimer's DiseaseMedicineDementiaVascular DementiaNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeuroscienceNeurologyNeurodegenerationPharmacologyMulti-target InhibitorsCholinergic DeficitLewy Body Dementia